Reagents and consumables

Ended Awarded Last action

Contract number
75N91020F00002
Awardee
Awarding agency
Obligated
$10,019

Award facts

Opportunity
Contract value 100% obligated
$10,019.11 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute issued a delivery order to Roche Diagnostics Corporation on November 20, 2019, with a ceiling value of $10,019.11 for reagents and consumables for Ventana Medical Systems Benchmark Ultra immunostainers. Place of performance is Bethesda, MD. The order was firm fixed price with an ultimate completion date of December 20, 2019. No set-aside was used.

Quick answers

Who was awarded contract 75N91020F00002?

75N91020F00002 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on November 20, 2019.

How much is contract 75N91020F00002 worth?

The government has obligated $10,019 on 75N91020F00002.

Is contract 75N91020F00002 an order under another contract?

Yes. 75N91020F00002 is a delivery order under 75N91019D00038, an indefinite delivery contract.

Was contract 75N91020F00002 competed?

The extent of competition for 75N91020F00002 was not competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award